A Study of Contrast-enhanced EBUS in Lung Lesions and Intrathoracic Lymph Nodes

Recruiting now · Not applicable

Conditions studied: Lung Lesions, Mediastinal and Hilar Lymph Node Enlargement

In brief

Exploring the Clinical Application Value of Contrast Enhancement Features in CE-EBUS Images for the Diagnosis of Pulmonary Lesions and Intrapulmonary Lymph Nodes

Key facts

Study ID

NCT07060378

Run by

Shanghai Chest Hospital

People needed

250

Starts

2025-07-10

Expected to finish

2026-01-30

Last updated by the study team

2025-07-11

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age >18 years old；
• Enlargement of at least one intrathoracic LN (short diameter > 1 cm) or central parenchymal lung lesions adjacent to the airway detected on chest CT, or increased fluorodeoxyglucose uptake in at least one intrathoracic lymph node on PET / CT (standardized uptake value > 2.5)；
• CP-EBUS-TBNA is required to determine the diagnosis or staging, the patient agreed to undergo CE-EBUS, and there were no contraindications to EBUS-TBNA;
• Patients who have good compliance and sign informed consent.

You may not qualify if…

• Patients with known hypersensitivity to ultrasound contrast components;
• Patients with severe pulmonary hypertension (pulmonary artery pressure > 90 mmHg);
• Patients with angina pectoris, acute coronary syndrome, clinically unstable ischemic heart disease, heart failure, cardiac dysfunction, and cardiac disease with right-to-left shunting;
• Patients with uncontrolled essential hypertension and adults with respiratory distress syndrome;
• Pregnant or lactating women；
• Patients with contraindications to bronchoscopy；
• Patients with other conditions that, in the opinion of the investigator, make the patient unsuitable for the study.

Where it is running

• Shanghai Chest Hospital — Shanghai, Shanghai Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.